Drug intelligence / Profile preview

Composite Microporous Polysaccharide Hemostatic Powder

Development stage: Unknown
Lead developer: Success Biotech
Administration: Topical

Overview

This product is a hemostatic powder composed of starch polysaccharide and carboxymethyl chitosan, which are cross-linked to form a microporous structure. It is used for hemostasis in various surgical and traumatic bleeding sites. The mechanism involves absorbing water from blood, forming a gel that mechanically seals blood vessel openings and enhances endogenous coagulation mechanisms[1][4][7].

Other names: 复合微孔多聚糖止血粉

Beyond the preview

Go deeper on Composite Microporous Polysaccharide Hemostatic Powder.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Composite Microporous Polysaccharide Hemostatic Powder.

Explore the full profile